BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35919827)

  • 1. Interpretation of the National Action Plan for Eliminating Hepatitis C as a Public Health Threat (2021-2030).
    Li J; Pang L; Liu Z
    China CDC Wkly; 2022 Jul; 4(29):627-630. PubMed ID: 35919827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elimination of hepatitis C, our progress, challenges and hopes].
    Rao HY; Li MY; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):809-811. PubMed ID: 33105921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017.
    Smith S; Harmanci H; Hutin Y; Hess S; Bulterys M; Peck R; Rewari B; Mozalevskis A; Shibeshi M; Mumba M; Le LV; Ishikawa N; Nolna D; Sereno L; Gore C; Goldberg DJ; Hutchinson S
    JHEP Rep; 2019 Aug; 1(2):81-89. PubMed ID: 32039355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
    Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J;
    Liver Int; 2019 Jan; 39(1):20-30. PubMed ID: 30157316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In-hospital process for viral hepatitis C screening and management in China (Draft)].
    ; ; ;
    Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):319-325. PubMed ID: 33979957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis in Asia].
    Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exploring the health education model for chronic hepatitis C micro-elimination in Guizhou Province from a global perspectives].
    Luo XH; Liang YD; Peng H; Ning JH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):816-819. PubMed ID: 33105923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress and challenges in achieving the WHO goal on 'Elimination of Hepatitis B by 2030' in China].
    Liu J; Liu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):605-609. PubMed ID: 31238605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Countdown to 2030: eliminating hepatitis B disease, China.
    Liu J; Liang W; Jing W; Liu M
    Bull World Health Organ; 2019 Mar; 97(3):230-238. PubMed ID: 30992636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What China can learn from Malaysia to achieve the goal of "eliminate hepatitis C as a public health threat" by 2030 - a narrative review.
    Sun J; Cheng H; Hassan MRA; Chan HK; Piedagnel JM
    Lancet Reg Health West Pac; 2021 Nov; 16():100261. PubMed ID: 34590064
    [No Abstract]   [Full Text] [Related]  

  • 11. Eliminate Hepatitis C as a Public Health Threat: A Narrative Review of Strategies, Gaps, and Opportunities for China.
    Song Y; Li Y; Cheng H; Du X; Mi J; Le LV; Chen Z; Chan P; Sun J
    Infect Dis Ther; 2022 Aug; 11(4):1427-1442. PubMed ID: 35821355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating the elimination of hepatitis C in Kuwait: An expert opinion.
    Hasan F; Alfadhli A; Al-Gharabally A; Alkhaldi M; Colombo M; Lazarus JV
    World J Gastroenterol; 2020 Aug; 26(30):4415-4427. PubMed ID: 32874054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of hepatitis C virus testing in National Health Screening to accelerate HCV elimination in South Korea.
    Jee Y
    Glob Health Med; 2021 Oct; 3(5):288-292. PubMed ID: 34782871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional progress towards hepatitis C elimination in the Western Pacific Region, 2015-2020.
    Chan PL; Le LV; Ishikawa N; Easterbrook P
    Glob Health Med; 2021 Oct; 3(5):253-261. PubMed ID: 34782866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus elimination status and strategies in circumpolar countries, 2020.
    Haering C; McMahon B; Harris A; Weis N; Lundberg Ederth J; Axelsson M; Olafsson S; Osiowy C; Tomas K; Bollerup S; Liitsola K; Archibald C; Blystad H; Bruce M; Nolen L
    Int J Circumpolar Health; 2021 Dec; 80(1):1986975. PubMed ID: 34668463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Cascades: Data to Inform Hepatitis C Elimination in the United States.
    Montgomery MP; Randall LM; Morrison M; Gupta N; Doshani M; Teshale E
    Public Health Rep; 2023 Sep; ():333549231193508. PubMed ID: 37667621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access.
    Maponga TG; Matteau Matsha R; Morin S; Scheibe A; Swan T; Andrieux-Meyer I; Spearman CW; Klein MB; Rockstroh JK
    Hepatol Med Policy; 2017; 2():8. PubMed ID: 30288321
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.